Switch to:
More From Other Websites
Gilead Has a Problem. These Three Biotechs Could Be the Solution Jul 22 2016
TESARO to Announce Second-Quarter 2016 Financial Results on August 4, 2016 Jul 21 2016
Coverage initiated on Tesaro by Robert W. Baird Jul 19 2016
10 Stocks That Could Ruin Your Retirement Jul 15 2016
ENGOT and TESARO Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial Jul 08 2016
ENGOT and TESARO Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial Jul 08 2016
TESARO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Jul 07 2016
TESARO Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters Jul 07 2016
TESARO Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters Jul 07 2016
Steven Cohen Hits Another Home Run in Oncology Jul 07 2016
Buyout target Medivation says cancer drug could be 'best in class' Jul 06 2016
​Tesaro raises $377M in largest local biotech stock offering in the past year Jul 01 2016
Tesaro (TSRO) in Focus: Stock Adds 8.6% in Session Jul 01 2016
TESARO Announces Pricing of Public Offering of Common Stock Jun 30 2016
TESARO Announces Pricing of Public Offering of Common Stock Jun 30 2016
Tesaro Stock Up on Successful Phase III Ovarian Cancer Trial Jun 30 2016
Here’s Why Traders Are Buzzing Around Lions Gate, Stellar Biotechnologies, and Three Other Stocks Jun 30 2016
Protect Gains Into the Holiday Weekend Jun 30 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK